Welcome to our dedicated page for Zions Bancorporation N A SEC filings (Ticker: ZION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zions Bancorporation, N.A. filings document a regional banking issuer with common stock and Series A preferred shares. Form 8-K reports include quarterly operating results and financial-condition presentations, completed investment sales, annual meeting voting outcomes, and other material events tied to the Bank’s balance sheet and governance.
Proxy materials and shareholder-vote reports cover director elections, auditor ratification, executive compensation votes, shareholder proposals, and governance controls. The filings also describe risk areas tied to its banking model, including loan and securities portfolio quality, deposit composition, interest-rate conditions, macroeconomic factors, and regulatory outcomes.
Zions Bancorporation (ZION) reported an insider transaction on a Form 4 for a director. On 10/03/2025, the reporting person acquired 523.549 derivative securities labeled as deferred compensation/phantom stock units at a stated price of $0.
Following this transaction, the director’s derivative holdings totaled 35,763.941 units, shown as directly owned. The filing notes these phantom stock units are settled in cash upon the earlier of death or retirement, indicating they are cash-settled awards tied to the value of common stock rather than shares issued.
Zions Bancorporation, N.A. announced financial results for the quarter ended September 30, 2025, and will host a conference call at 5:30 p.m. Eastern Time on October 20, 2025.
The company furnished a press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2). The information is furnished under Item 2.02 and is not deemed filed under Section 18 or incorporated by reference.
Zions Bancorporation, N.A. reported an issue related to two commercial and industrial loans at its California Bank & Trust division. The company recorded an approximately $60 million provision tied to these loans and a $50 million charge-off. These amounts will be reflected in results for the third quarter of 2025.
The company conducted an internal review of the borrowers, guarantors, the loans, and the collateral after becoming aware of related legal actions by other lenders. Following notices to counterparties that went unanswered, Zions recognized the provision and charge-off and indicated it believes the situation is isolated. The company plans to engage counsel to coordinate an independent review.
Lee Vivian S, a director of ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION), reported a Form 4 disclosing a transaction dated 10/03/2025. The filing shows an acquisition of 501.735 deferred compensation/phantom stock units (transaction code A) that are recorded with a $0 per-unit price and a noted underlying common stock amount of 25,650.812 shares listed as beneficially owned following the transaction. The filing states the phantom stock units are settled in cash upon the earlier of death or retirement. The report was signed on 10/06/2025 by an attorney-in-fact. This disclosure documents officer/director holdings and a compensation-related award but does not include sale activity or cash proceeds.
Stephen D. Quinn, a director of Zions Bancorporation, National Association (ZION), reported an acquisition of 846.405 deferred compensation phantom stock units on 10/03/2025. The units are recorded with a $0 per‑unit price and will be settled in cash upon the earlier of death or retirement. After the reported acquisition the filing shows total beneficial ownership of 122,493.706 shares (direct).
Claire A. Huang, a director of ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION), received 532.275 phantom stock units under a deferred compensation arrangement. The phantom units are settled in cash upon the earlier of death or retirement, creating a future cash obligation tied to the company’s common stock value. After the grant, Ms. Huang is reported to directly beneficially own 31,074.542 shares of common stock. The transaction was reported as an acquisition of a derivative-style award rather than a direct stock purchase, and the form was submitted by a single reporting person filing through an authorized attorney-in-fact.